Log in
Enquire now
Mosanna Therapeutics

Mosanna Therapeutics

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2C
B2C
CEO
David Weber
David Weber
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@mosanna.com
Founded Date
2022
Headquarters
Basel
Basel
Industry
Health technology
Health technology
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Manufacturing
Manufacturing
Investors
Forty51 Ventures
Forty51 Ventures
‌
Supermoon Capital
EQT Life Sciences
EQT Life Sciences
Norwest Venture Partners
Norwest Venture Partners
High-Tech Gründerfonds
High-Tech Gründerfonds
Forbion Capital Partners
Forbion Capital Partners
Broadview Ventures
Broadview Ventures
Pivotal bioVenture Partners
Pivotal bioVenture Partners
Latest Funding Round Date
June 10, 2025
Latest Funding Round Amount (USD)
80,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/mosanna-therapeutics
Location
Switzerland
Switzerland
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
80,000,000
Official Website
mosanna.com

Find more companies like Mosanna Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.